Jonathan David Schwartz Net Worth & Insider Trades
Jonathan David Schwartz - See Remarks, Rocket Pharmaceuticals, Inc
What is Jonathan David Schwartz's Net Worth?
The current estimated net worth of Rocket Pharmaceuticals, Inc's See Remarks, Jonathan David Schwartz, is estimated to be about $5.76M . Jonathan David Schwartz owns about 94,546 units of Rocket Pharmaceuticals, Inc common stock. In the last year at Rocket Pharmaceuticals, Inc, Jonathan David Schwartz has sold an estimated value of $806.45K worth.
What is Jonathan David Schwartz's Past Insider Trading?
Jonathan David Schwartz's largest sale order was 45,000 units , worth over $738.65K on April 1, 2022. In total, Jonathan David Schwartz has made about 5 transactions over a year of their time at Rocket Pharmaceuticals, Inc. Jonathan David Schwartz usually trades in February, with the busiest year in 2022. The most recent transaction was a sale order of 3,557 units , worth over $67.8K on February 22, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Jonathan David Schwartz
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Jonathan David Schwartz's Salary in 2020?
The vast majority of their compensation came in the form of other earnings, plans or compensations of $1,870,733 , option awards of $1,251,033 , and other compensation of $11,400 .
What is Jonathan David Schwartz's' Mailing Address?
- Mailing address is 430 East 29th Street Suite 1040 New York NY 10016 NY
Rocket Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|
| Gaurav D. Shah, M.D. | 2020 | $6,859,135 | $6,859,135 | $5,821,735 | $11,400 | $6,859,135 |
| Gaurav D. Shah, M.D. | 2019 | $3,883,646 | $3,883,646 | $3,043,306 | $11,200 | $3,883,646 |
| Gaurav D. Shah, M.D. | 2018 | $6,375,752 | $6,375,752 | $5,651,220 | $9,857 | $6,375,752 |
| Kinnari Patel, Pharm.D., MBA | 2020 | $4,080,621 | $4,080,621 | $3,254,721 | $11,400 | $4,080,621 |
| Kinnari Patel, Pharm.D., MBA | 2019 | $2,776,209 | $2,776,209 | $2,092,294 | $11,200 | $2,776,209 |
| Kinnari Patel, Pharm.D., MBA | 2018 | $2,991,073 | $2,991,073 | $2,423,050 | $11,066 | $2,991,073 |
| Jonathan Schwartz, M.D., | 2020 | $1,870,733 | $1,870,733 | $1,251,033 | $11,400 | $1,870,733 |
| Jonathan Schwartz, M.D., | 2019 | $1,475,675 | $1,475,675 | $937,261 | $8,165 | $1,475,675 |
| Jonathan Schwartz, M.D., | 2018 | $1,356,675 | $1,356,675 | $830,761 | $8,854 | $1,356,675 |
| Kamran Alam | 2020 | $634,250 | $634,250 | $427,670 | $9,350 | $634,250 |
| Kamran Alam | 2019 | $2,051,457 | $2,051,457 | $1,916,912 | - | $2,051,457 |
| John Militello, Controller and Treasurer Principal Controller and Treasurer Principal | 2020 | $1,003,053 | $1,003,053 | $617,270 | $11,400 | $1,003,053 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1281895/000114036121015285/nc10023585x1_def14a.htm
What are Rocket Pharmaceuticals, Inc's Past Insider Trades?
Rocket Pharmaceuticals, Inc's most recent insider trade came on October 2, 2023 by Gotham Makker who sold 14,989 units worth $315.74K . In the last 5 years, insiders at Rocket Pharmaceuticals, Inc have sold an estimated value of $64.56M and bought an estimated value of $111.49M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are Roderick Wong, Director, John Militello, See Remarks, and Kinnari Patel, See Remarks .
ROCKET PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||